首页> 外文期刊>Osteoarthritis and cartilage >Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects - results at 12 and 18 months.
【24h】

Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects - results at 12 and 18 months.

机译:通过胶原膜在马关节缺损中进行自体软骨细胞移植的评估-结果分别为12和18个月。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate a technique of autologous chondrocyte implantation (ACI) similar to the other techniques using cell-seeded resorbable collagen membranes in large articular defects. METHODS: Autologous cartilage was harvested arthroscopically from the lateral trochlear ridge of the femur in fifteen 3-year-old horses. After culture and expansion of chondrocytes the newly created ACI construct (autologous chondrocytes cultured expanded, seeded on a collagen membrane, porcine small intestine submucosa) was implanted into 15mm defects on the medial trochlear ridge of the femur in the opposite femoropatellar joint. Using two defects in each horse, the ACI technique was compared to collagen membrane alone (CMA) and empty cartilage defects (ECDs). RESULTS: Arthroscopic evaluations at 4, 8, 12 and 18 months demonstrated that CMA was significantly worse compared to ACI or ECD treatments, with ACI having the best overall subjective grade. Overall raw histological scores demonstrated a significant improvement with ACI compared to either CMA or ECD treated defects and ACI defects had significantly more immunohistochemical staining for aggrecan than CMA or ECD treated defects (with significantly more type II collagen in ACI and ECD compared to CMA defects) at 12 and 18 months. CONCLUSIONS: Histologic and immunohistochemistry results from this long-term randomized study are particularly encouraging and demonstrate superiority with the ACI technique. Although there is no comparable study published with the traditional ACI technique in the horse (or with such a large defect size in another animal model), the use of a solid autologous cell-seeded-constructed implant would appear to offer considerable clinical advantages.
机译:目的:评估与其他技术相似的自体软骨细胞植入(ACI)技术,该技术使用细胞接种的可吸收胶原膜处理大关节缺损。方法:关节镜下从15个3岁大马的股骨外侧滑车脊收集自体软骨。在培养和扩增软骨细胞后,将新创建的ACI构建体(培养的自体软骨细胞扩增,接种在胶原膜上,猪小肠粘膜下层)植入相对的股骨joint内股骨内滑车上15mm的缺损中。在每匹马中使用两个缺陷,将ACI技术与单独的胶原膜(CMA)和空软骨缺陷(ECD)进行了比较。结果:在第4、8、12和18个月的关节镜检查显示,与ACI或ECD治疗相比,CMA明显较差,ACI总体主观评分最高。总体原始组织学评分显示,与CMA或ECD处理的缺损相比,ACI改善显着,ACI缺损对聚集蛋白聚糖的免疫组织化学染色明显高于CMA或ECD处理的缺损(与CMA缺损相比,ACI和ECD中的II型胶原明显增多)在12和18个月时。结论:这项长期随机研究的组织学和免疫组化结果特别令人鼓舞,并证明了其与ACI技术的优越性。尽管目前尚无与传统ACI技术相匹敌的研究(或在另一只动物模型中具有如此大的缺陷尺寸)发表,但使用固体自体细胞种子构建的植入物似乎具有相当大的临床优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号